Skip to main content
MITI
OTC Technology

Mitesco Discloses Over 20 Million New Shares Issued After Quarter-End, Doubling Share Count

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.026
Mkt Cap
$550.738K
52W Low
$0.025
52W High
$0.398
52W Position info
4.8% above low
Off High info
93% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

MITI is trading near its 52-week low of $0.025 (4.8% above the low).

Summary

Mitesco's Q2 10-Q shows a company in critical distress: $8,000 cash, $22.4M current liabilities, and over 20 million new shares issued after quarter-end, more than doubling the share count.


Key Events · Earnings and Guidance · MITI

  • Massive Post-Quarter Share Issuance

    Subsequent to June 30, 2026, the company issued over 20 million restricted shares to advisors, Robo Agent developers, consultants, Dawson James Securities, Anglo Irish Management, and each board member — more than doubling the 20.9 million shares outstanding at quarter-end.

  • Critical Cash Position

    Cash fell to $7,984 at June 30, 2026, and further to approximately $5,700 by August 17, 2026, against current liabilities of $22.4 million.

  • Going Concern Warning

    The company reiterates substantial doubt about its ability to continue as a going concern, with no formal funding agreement in place.

  • New High-Cost Debt

    After quarter-end, Mitesco entered into short-term notes totaling $200,000 with 20% original issue discounts and default provisions that increase balances to 130%.


Analysis · MITI · Technology

The 10-Q reveals that after June 30, 2026, Mitesco issued over 20 million restricted shares to advisors, developers, consultants, and board members — more than doubling the 20.9 million shares outstanding at quarter-end. Combined with new high-cost short-term notes and continued Series A redemptions, this accelerates the dilution spiral for a company with only $8,000 in cash and $22.4 million in current liabilities. The going concern warning remains, and the massive insider and advisor compensation in stock signals severe cash constraints.

At the time of this filing, MITI was trading at $0.03 on OTC in the Technology sector, with a market capitalization of approximately $550.7K. The 52-week trading range was $0.03 to $0.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MITI - Latest Insights

MITI
Aug 10, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.0343
Real-time Price: $0.0263 info
Change: -$0.0080 (-23%) info
Market Cap: $550.738K info
MITI
Aug 04, 2026, 7:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.035
Real-time Price: $0.0263 info
Change: -$0.0087 (-25%) info
Market Cap: $550.738K info
MITI
Jul 21, 2026, 5:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0975
Real-time Price: $0.0263 info
Change: -$0.0712 (-73%) info
Market Cap: $550.738K info
MITI
Jul 09, 2026, 4:13 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.070
Real-time Price: $0.0263 info
Change: -$0.0437 (-62%) info
Market Cap: $550.738K info
MITI
Jul 02, 2026, 7:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.075468
Real-time Price: $0.0263 info
Change: -$0.049168 (-65%) info
Market Cap: $550.738K info